Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Interpretable machine learning for prediction of leptomeningeal metastasis in lung adenocarcinoma: a multi-centre retrospective study via “Prompt” model. Local targets link to admitted publications; unresolved targets remain external evidence.
Leptomeningeal metastasis from non-small cell lung cancer and current landscape of treatments
10.1158/1078-0432.ccr-22-1585 · 2023 · External reference
Leptomeningeal metastases in the mri era
10.1212/wnl.0b013e3181dc1a69 · 2010 · External reference
Management of leptomeningeal metastases in non-oncogene addicted non-small cell lung cancer
10.3389/fonc.2018.00278 · 2018 · External reference
Clinical utility of cerebrospinal fluid cell-free DNA as liquid biopsy for leptomeningeal metastases in alk-rearranged nsclc
10.1016/j.jtho.2019.01.007 · 2019 · External reference
Leptomeningeal metastases in patients with nsclc with egfr mutations
10.1016/j.jtho.2016.06.029 · 2016 · External reference
Impact of egfr tyrosine kinase inhibitors versus chemotherapy on the development of leptomeningeal metastasis in never smokers with advanced adenocarcinoma of the lung
10.1007/s11060-013-1199-y · 2013 · External reference
Estimated worldwide variation and trends in incidence of lung cancer by histological subtype in 2022 and over time: A population-based study
10.1016/s2213-2600(24)00428-4 · 2025 · External reference
Epidermal growth factor receptor tyrosine kinase inhibitors for non-small-cell lung cancer patients with leptomeningeal carcinomatosis
10.1097/jto.0000000000000669 · 2015 · External reference
Leptomeningeal metastasis from systemic cancer
10.1212/01.con.0000413661.58045.e7 · 2012 · External reference
Mr imaging of leptomeningeal metastases: Comparison of three sequences
2002 · External reference
Leptomeningeal carcinomatosis in non-small cell lung cancer patients: A continuing challenge in the personalized treatment era
10.1016/j.ctrv.2016.12.006 · 2017 · External reference
Association of mri findings with clinical characteristics and prognosis in patients with leptomeningeal carcinomatosis from non-small cell lung cancer
10.1007/s11060-019-03190-3 · 2019 · External reference
Intrathecal chemotherapy for treatment of leptomeningeal dissemination of metastatic tumours
10.1016/s1470-2045(10)70034-6 · 2010 · External reference
Evaluating the impact of artificial intelligence in antimicrobial stewardship: A comparative meta-analysis with traditional risk scoring systems
10.1016/j.idnow.2025.105090 · 2025 · External reference
Accurate predictions on small data with a tabular foundation model
10.1038/s41586-024-08328-6 · 2025 · External reference
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (tripod): The tripod statement
10.1136/bmj.g7594 · 2015 · External reference
Clinical outcome in patients with leptomeningeal metastasis from non-small cell lung cancer: Okayama lung cancer study group
10.1016/j.lungcan.2012.03.002 · 2012 · External reference
Cancer risk prediction using machine learning for supporting early cancer diagnosis in symptomatic patients: A systematic review of model types
10.1002/cam4.71463 · 2025 · External reference
Brain parenchymal and leptomeningeal metastasis in non-small cell lung cancer
10.1038/s41598-022-26131-z · 2022 · External reference
Development and validation of a nomogram to predict leptomeningeal metastases in lung adenocarcinoma: Cervical lymph node metastasis is an important association factor
10.1002/cam4.7206 · 2024 · External reference
A molecular graded prognostic assessment (molgpa) model specific for estimating survival in lung cancer patients with leptomeningeal metastases
10.1016/j.lungcan.2019.03.015 · 2019 · External reference
Systematic immunological level determined the prognosis of leptomeningeal metastasis in lung cancer
10.2147/cmar.s347323 · 2022 · External reference
Leptomeningeal metastases in non-small cell lung cancer: Diagnosis and treatment
10.1016/j.lungcan.2022.09.013 · 2022 · External reference
Tumor microenvironment signaling and therapeutics in cancer progression
10.1002/cac2.12416 · 2023 · External reference
The metabolism of cancer cells during metastasis
10.1038/s41568-020-00320-2 · 2021 · External reference
The crosstalk between pattern-recognition receptor signaling and calcium signaling
10.1016/j.ijbiomac.2021.10.014 · 2021 · External reference
Calcium homeostasis and cancer: Insights from endoplasmic reticulum-centered organelle communications
10.1016/j.tcb.2022.07.004 · 2023 · External reference
Calcium channel blocker lacidipine promotes antitumor immunity by reprogramming tryptophan metabolism
10.1002/advs.202409310 · 2025 · External reference
Leptomeningeal metastases in non-small-cell lung cancer
10.1016/s1470-2045(17)30689-7 · 2018 · External reference
Patients with non-small cell lung cancer with the exon 21 l858r mutation: From distinct mechanisms to epidermal growth factor receptor tyrosine kinase inhibitor treatments (review)
10.3892/ol.2024.14855 · 2025 · External reference
Egfr-l858r mutant enhances lung adenocarcinoma cell invasive ability and promotes Malignant pleural effusion formation through activation of the cxcl12-cxcr4 pathway
10.1038/srep13574 · 2015 · External reference
Spurious electrolyte and acid-base disorders in the patient with cancer: A review
10.1053/j.ajkd.2023.01.441 · 2023 · External reference
Electrolyte disorders in oncological patients
10.1016/j.bulcan.2023.04.014 · 2024 · External reference
Electrolytes disturbances in cancer patients
10.1097/mnh.0000000000000819 · 2022 · External reference
